# Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation

> **NCT02995642** · PHASE2 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Aortic Aneurysm, Abdominal
- Carotid Atherosclerosis

## Interventions

- **DRUG:** 18F-FPPRGD2
- **DEVICE:** Positron emission tomography
- **PROCEDURE:** Computed tomography
- **DEVICE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT02995642
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Resources not secured
- **Last updated:** 2021-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995642, "Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02995642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*